This mouse holds the advantage of bearing a bona fide mitochondrial disease mutation seen in a family with Leigh syndrome, unlike the deletion of exon 2 in ndufs4, which has not been described in humans. This evidence concerns the gene NDUFS4 and mitochondrial disease.